テキサスにおける濾胞性リンパ腫の臨床試験
テキサス内の拠点で、濾胞性リンパ腫に関する35件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- NEXT Dallas, Irving
- NEXT Oncology, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT03460977Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Texas Children's Hospital, Houston
被験者募集中観察研究
0歳〜38歳 · 全性別 · 2026/10/01更新 · NCT06131801A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Research Site, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06542250A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Md Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05006716A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Texas Oncology - DFW (Sammons CC), Dallas
- Baylor College of Medicine, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- University of Texas Southwestern, Dallas
- MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07101328A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Baylor Scott & White Research Institute, Dallas
- The University of Texas MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics (START), San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT05765812A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Austin
- Research Site, Lubbock
- Research Site, Shenandoah
- 他1件
被験者募集中第3相
18歳〜130歳 · 全性別 · 2026/09/21更新 · NCT06549595NEO100 and High-Grade Meningioma
- Baylor Scott and White, Dallas
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/15更新 · NCT05023018Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Research Site, Austin
- Research Site, Houston
- Research Site, San Antonio
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06526793Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Texas Oncology, Dallas
被験者募集中第3相
12歳〜100歳 · 全性別 · 2026/09/11更新 · NCT06784752A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- Center for Oncology and Blood Disorders, Houston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06091254A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
- MD Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06043323A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
- Research Site, San Antonio
被験者募集中第1相健康なボランティア歓迎
18歳〜85歳 · 全性別 · 2026/09/01更新 · NCT07546760Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
- M D Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/31更新 · NCT06108232SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Texas Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
- University of Texas Health Mays Cancer Center, San Antonio
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Baylor University Medical Center, Dallas
- Texas Transplant Institute, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT05826535Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- University of Texas MD Anderson Cancer Center, Houston
被験者募集中第1/2相
13歳〜90歳 · 全性別 · 2026/08/06更新 · NCT06533579Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
- Natera, Inc., Austin
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/06更新 · NCT07750886A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- The University of TX MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/30更新 · NCT07424833Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
- Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston, Houston
- The University of Texas Health Science at San Antonio, San Antonio
被験者募集中第2相
18歳〜55歳 · 全性別 · 2026/07/15更新 · NCT05951777A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/02更新 · NCT05131022A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
- Texas Liver Institute - American Research Corporation, San Antonio
- Pinnacle Clinical Research, San Antonio
被験者募集中第1相
18歳〜80歳 · 全性別 · 2026/06/16更新 · NCT07559474A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Texas Oncology - Central/South Texas, Austin
- Local Institution - 0212, Fort Worth
- Local Institution - 0230, San Antonio
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/20更新 · NCT06911502The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
被験者募集中第1/2相
12歳〜95歳 · 全性別 · 2026/04/15更新 · NCT04329728A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
- MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/20更新 · NCT04830137Study of SGR-1505 in Mature B-Cell Neoplasms
- University of Texas Southwestern, Dallas
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT05544019Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
- University of Texas Medical Branch at Galveston, TX, Galveston
被験者募集中
50歳以上 · 女性 · 2026/02/11更新 · NCT07206121Cognitive Screening Made Easy for PCPs - Administrative Supplement
- Family Wellness Clinic, Austin
- University of Texas Health Austin Primary Care Clinic, Austin
- UT Health San Antonio's Geriatrics and Supportive Care Clinic, San Antonio
被験者募集中健康なボランティア歓迎
60歳以上 · 全性別 · 2026/02/05更新 · NCT06928298AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Oncology Consultants, Houston
- University of Texas MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2025/12/10更新 · NCT05602363A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
- SCRI, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/14更新 · NCT05643742SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Dallas
- Massive Bio SYNERGY-AI site, Houston
- Massive Bio SYNERGY-AI site, Temple
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- University of Texas Southwestern Medical Center, Dallas
被験者募集中第1相
18歳以上 · 全性別 · 2025/10/02更新 · NCT05780034Phosphatidylethanol and Other Ethanol Consumption Markers
- University of North Texas, Denton
- University of Texas Health Science Center San Antonio, San Antonio
被験者募集中健康なボランティア歓迎
21歳以上 · 全性別 · 2025/05/13更新 · NCT06747364Paper-Based and Smartphone-Based Memory Supports
- UT Health Austin Comprehensive Memory Center, Austin
- Baylor Scott & White Healthcare, Temple
- Baylor University, Waco
被験者募集中
50歳以上 · 全性別 · 2024/07/09更新 · NCT06444841ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。